Skip to content

CA-1511, In Vitro Radioimmunoassay

by Travenol Laboratories, S.A.

510(k) K841821

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK841821 Date22 Jun 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JHI
Device Class
Class II
Regulation
21 CFR Part 862.1155
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The CA-1511, In Vitro Radioimmunoassay is a diagnostic test system used for the quantitative measurement of human chorionic gonadotropin (hCG) in serum or plasma specimens. It is classified as a Class II medical device under FDA regulation 862.1155 and falls within the Clinical Chemistry specialty.

This device received FDA 510(k) clearance (K841821) on June 22, 1984, and is substantially equivalent to a legally marketed predicate device. It is intended for prescription use and is manufactured by Travenol Laboratories, S.A. The device is supplied as an in vitro assay kit for laboratory use.

Other devices from Travenol Laboratories, S.A.

See all devices from Travenol Laboratories, S.A. →

Questions

AI-generated answers, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the CA-1511 In Vitro Radioimmunoassay used for?

    The CA-1511 is a diagnostic test system used for the quantitative measurement of human chorionic gonadotropin (hCG) in serum or plasma specimens. It is designed for laboratory use and is intended for prescription purposes.

  • How is the CA-1511 Radioimmunoassay supplied?

    The device is supplied as an in vitro assay kit for laboratory use. It contains all necessary components for performing the quantitative measurement of hCG in serum or plasma specimens according to the manufacturer's instructions.

  • What is the regulatory status of the CA-1511 Radioimmunoassay?

    The CA-1511 received FDA 510(k) clearance (K841821) on June 22, 1984, and is classified as a Class II medical device under FDA regulation 862.1155. It is substantially equivalent to a legally marketed predicate device.

  • What is the intended use of the CA-1511 test system?

    The CA-1511 is intended for the quantitative measurement of human chorionic gonadotropin (hCG) in serum or plasma specimens. This measurement is typically used in clinical settings for various diagnostic purposes related to pregnancy and other conditions.